DK1148129T3 - Modifikation af betacellulin - Google Patents

Modifikation af betacellulin

Info

Publication number
DK1148129T3
DK1148129T3 DK99959698T DK99959698T DK1148129T3 DK 1148129 T3 DK1148129 T3 DK 1148129T3 DK 99959698 T DK99959698 T DK 99959698T DK 99959698 T DK99959698 T DK 99959698T DK 1148129 T3 DK1148129 T3 DK 1148129T3
Authority
DK
Denmark
Prior art keywords
betacellulin
modification
activity
antigenicity
diabetes
Prior art date
Application number
DK99959698T
Other languages
English (en)
Inventor
Takashi Ito
Mitsuyo Kondo
Yoko Tanaka
Masayuki Kobayashi
Koichi Igarashi
Reiko Sasada
Osamu Nishimura
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of DK1148129T3 publication Critical patent/DK1148129T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99959698T 1998-12-09 1999-12-08 Modifikation af betacellulin DK1148129T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35037798 1998-12-09
JP5532699 1999-03-03
PCT/JP1999/006873 WO2000034478A1 (fr) 1998-12-09 1999-12-08 Modification de betacelluline

Publications (1)

Publication Number Publication Date
DK1148129T3 true DK1148129T3 (da) 2007-10-15

Family

ID=26396224

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99959698T DK1148129T3 (da) 1998-12-09 1999-12-08 Modifikation af betacellulin

Country Status (11)

Country Link
US (1) US6825165B1 (da)
EP (1) EP1148129B1 (da)
AT (1) ATE368111T1 (da)
AU (1) AU1681100A (da)
CA (1) CA2353909C (da)
CY (1) CY1106882T1 (da)
DE (1) DE69936666T2 (da)
DK (1) DK1148129T3 (da)
ES (1) ES2288034T3 (da)
PT (1) PT1148129E (da)
WO (1) WO2000034478A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012707A1 (en) * 2004-08-06 2006-02-09 Gropep Limited Method for treating diabetes
CA2609728A1 (en) * 2005-05-27 2006-11-30 Five Prime Therapeutics, Inc. Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
CA3176556A1 (en) 2020-07-16 2022-01-20 Novartis Ag Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2099304T3 (es) 1992-02-10 1997-05-16 Takeda Chemical Industries Ltd Mitogeno de la musculatura lisa y adn que lo codifica.
US6410506B1 (en) * 1995-05-19 2002-06-25 Human Genome Sciences, Inc. Transforming growth factor α HII
DE69626034T2 (de) 1995-11-09 2003-08-14 Takeda Chemical Industries, Ltd. Zusammensetzung für verbesserung der pankreasfunktion
JPH10191989A (ja) * 1996-11-12 1998-07-28 Takeda Chem Ind Ltd ベータセルリン類の製造方法

Also Published As

Publication number Publication date
EP1148129B1 (en) 2007-07-25
AU1681100A (en) 2000-06-26
WO2000034478A1 (fr) 2000-06-15
CA2353909C (en) 2009-07-07
ATE368111T1 (de) 2007-08-15
CY1106882T1 (el) 2012-09-26
ES2288034T3 (es) 2007-12-16
US6825165B1 (en) 2004-11-30
PT1148129E (pt) 2007-09-05
CA2353909A1 (en) 2000-06-15
DE69936666D1 (de) 2007-09-06
DE69936666T2 (de) 2008-05-21
EP1148129A1 (en) 2001-10-24
EP1148129A4 (en) 2005-06-22

Similar Documents

Publication Publication Date Title
ATE226201T1 (de) Substituierte pyridylpyrazole
DE69633679D1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
DE69839279D1 (de) Neue physiologisch aktive substanz sulphostin, herstellung und verwendung derselben
ATE204754T1 (de) Pharmazeutische zusammensetzung von metformin und fibrat, und ihre verwendung zur behandlung von hyperglykämie
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
DE59310399D1 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
PT1191025E (pt) Cristais de lansoprazol
DE60231295D1 (de) R und ppar modulatoren
ATE232865T1 (de) 1,4-diazabicyclo(3.2.2)nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
ATE257844T1 (de) Menschlicher wachstumsfaktor (hgf), verändert durch polyethylenglykol
DE69021383D1 (de) Medizinisches beatmungsgerät.
FI912348A0 (fi) Stabiliserad fgf sammansaettning.
TR199801513A3 (tr) N-(4-Triflormetilfenil)- 5- metil-izoksazol-4-karboksamidin kristal formu.
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
CY1106882T1 (el) Τροποποιηση βητακυτταρουλινης
ATE250021T1 (de) Hydroxycyclopentanone
DE69003712D1 (de) Optisch aktive Verbindungen, ihre Herstellung und Verwendung.
DK0579939T3 (da) Phospholipidderivater
ATE203908T1 (de) Chromhaltiges mittel zur steuerung der cellulären glucoseaufnahme
DE59104129D1 (de) 2,2'-Thienyl-benzothiophene, ihre Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen.
DK0673913T3 (da) Calcium-alkalimetalcitratforbindelser samt deres anvendelse som lægemidler
FR2696311B1 (fr) Ballast jetable auto-compensé.
FR2680953B1 (fr) Semelle deodorante, antibacteries, hydrothermique jetable.
IT1271685B (it) Impiego dei polidesossiribonucleotidi nelle neuropati diabetiche